Emory University Investigational Drug Service — Atlanta, Georgia

Emory University Investigational Drug Service is a clinical research site located in Atlanta, Georgia, United States 30322.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Emory University Investigational Drug Service has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19.

Sponsors: BioNTech SE, Pfizer.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Emory University Investigational Drug Service?

Emory University Investigational Drug Service has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Emory University Investigational Drug Service conducted?

Emory University Investigational Drug Service has 3 clinical trials on record, with 1 currently active. Their work covers SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19.

Is Emory University Investigational Drug Service accredited by Crixeo Health?

Emory University Investigational Drug Service has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Emory University Investigational Drug Service?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.